Skip to main content
International
Ask us anything:
  • About
        • About We challenge convention so healthy can be possible for all
        • Our Story
          • Amneal at-a-glance
          • Our Founders
        • Our Purpose & Commitments
        • Our Culture
          • Learn, Lead, Succeed
          • Our Culture in Action
        • Our Milestones
        • Leadership
          • Executive Leadership
          • Board of Directors
        • Locations
        • Responsibility
          • Patient Assistance Programs
          • Product Donations
          • National & Local Philanthropy
          • Compliance and Ethics
        • Awards & Recognition
        • Amneal About
  • Products
        • Products We produce quality generic, specialty and biosimilar medicines
        • Our Portfolio
          • Generic Products
          • Specialty Products
          • Product Catalog
        • Quality
        • Drug Safety
          • Adverse Event Reporting
          • Medical Inquiries
          • Product Complaints
        • Operations
        • Amneal Products
  • Research & Development
        • Research & Development We invest significantly in new product development
        • Generics R&D
        • Specialty R&D
        • Product Partnering
        • Amneal Research and Technology
  • Investors
        • Investors Become an Informed Investor
        • Amneal Investors
  • News
  • Careers
        • Careers Join our quest to make healthy possible
        • Total Rewards
        • Search Our Career Opportunities
        • Amneal Careers
  • Contact
  • Customer Login
Amneal Pharmaceuticals
  • Investor Relations
  • Financial Reports
    • SEC Filings
    • Annual Reports
    • Quarterly & Other Reports
  • Events & Presentations
  • Stock Information
  • Corporate Governance
    • Policies
    • Executive Officers & Directors
    • Board Committees
  • Investor Resources
    • Analysts
    • Investor FAQ
    • Email Alerts
    • Information Request
    • RSS Feeds

Home Home  >  Financial Reports  >  SEC Filings

  • Investor Relations
  • Financial Reports
    • SEC Filings
    • Annual Reports
    • Quarterly & Other Reports
  • Events & Presentations
  • Stock Information
  • Corporate Governance
    • Policies
    • Executive Officers & Directors
    • Board Committees
  • Investor Resources
    • Analysts
    • Investor FAQ
    • Email Alerts
    • Information Request
    • RSS Feeds
SEC RSS Feed (opens in new window)
2021 2020 2019 2018 2017
Date Filing Type Filing Description Download
Dec 29, 2017
Form
S-4/A
Registration Statement for securities to be issued in business combination transactions
  • PDF Format Download (opens in new window)
  • Word Format Download (opens in new window)
  • Excel Format Download (opens in new window)
Nov 21, 2017
Form
S-4
Securities Registration: Business Combination
  • PDF Format Download (opens in new window)
  • Word Format Download (opens in new window)
  • Excel Format Download (opens in new window)

Investor Faq

Get answers to important investor relation questions.

More

Investor Tools

  • Email Alerts
  • RSS Feeds
  • Email Page

IR Contact

Get answers to your investor relation questions.

More
  • Privacy Policy
  • Copyright & Legal Disclaimer
  • Web Accessibility
© Amneal Pharmaceuticals LLC.
All rights reserved.
Powered By Q4 Inc. 5.49.0.3 (opens in new window)
Back to top